febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
febit technology is claimed to enable the conversion of new sequence data into biochips for Next-Generation Sequencing within days.

Kyoto University’s CiRA Purchases Fluidigm BioMark™ System for Stem Cell Reprogramming Research
CiRA uses Fluidigm technology to analyze selected genes in iPS cells and quantify copies of specific genes transferred into a cell to generate iPS cells.

Protein Structures Can Provide Keys to Understanding and Preventing Diseases of Catastrophic Proportions
Fluidigm’s TOPAZ® system helps researchers solve the structures of proteins from the Ebola Virus and Avian Flu Influenza.

Mingyuan Medicare Announces Collaboration with CHGC and SBC
Collaborations aims at major infectious diseases detecting platform in fight against human swine flu.

Phytronix and Agilent to Co-Market Phytronix LDTD Ion Source with Agilent Mass Spectrometers
The non-exclusive co-marketing agreement aims to promote the Phytronix Laser Diode Thermal Desorption Ion Source with Agilent mass spectrometers.

Cogenics Announces Global Availability of Standardized Drug Metabolizing Enzymes and Transporters Analysis Service
The new global pharmacogenetic test examines examine 1,936 drug metabolism markers in 225 genes.

InforSense and febit Announce OEM for Geniom Platform
febit embeds InforSense platform to support flexible microarray analysis.

Microfluidic PCR device for diagnostic pathogen detection
Molecular Medicine Unit

In this work a microfluidic cyclic flow PCR device is presented, which is capable of replicating the bacterial genomic DNA sequence of the 16S ribosomal RNA. The standard laboratory processing time of 3 h could be decreased to 60 min with the microfluidic reactor without loosing PCR efficiency. Integrating an optical fluorescence detector for dsDNA measurement would evolve this device into a micro total analysis system.

Design and Fabrication of a Micro PCR Module for POC Applications
Bruno Kessler Foundation (FBK)

The design and fabrication process of a micro PCR module is presented. The final system will be integrated in an innovative Lab on a Chip (LOC) to provide a technological platform able to detect autoimmune genetic diseases.

Fabrication and characterization of a fully integrated microdevice for in-vitro single cell assays
(1) FBK-BIOMEMS Unit, via Sommarive 18, 38123 Povo – TN – Italy, (2)Dipartimento di Ingegneria dell’informazione –University of Padova – 35131 Padova – Italy, (3) BioSiLab, 38068 Rovereto – TN – Italy

This work presents the microfabrication and preliminary characterization of a fully integrated microdevice for in-vitro single cell assays. This technological platform combines IDEs and MEA-based modules for cell addressed delivery of bio-functionalized nano/microparticles and single cell electroporation respectively.

Senior Director ADME
The RSA Group
Hatfield, Herts, UK

Mass Spectometry Scientist
Roswell Park Cancer Institute
Buffalo, NY, USA

Principal HTS Scientist
St. Jude Childrens Research Hospital
Memphis, TN, USA


Problems with Microarrays - A day filled with technical tips, Welwyn Garden City, UK
09 July 2009 - 09 July 2009

Learn how to perfect your microarray techniques and analysis at this Users Symposia. This one day event is designed as a small informal meeting for anyone with questions about microarrays.

Target Discovery World Congress, South San Francisco, CA, USA
04 August 2009 - 05 August 2009

Target Discovery World Congress will be a meeting focusing on the research looking to find new potential drugs for development. The topics will include presentations on the latest in screening platforms and new methods such as those in High Content and Label-Free Screening and will also focus on the work being done looking for new drug targets in some of the major protein families including Ion Channels, GPCRs, Protein Kinases, Nuclear Receptors and the Ubiquitin Pathway.

Molecular Diagnostics World Congress, South San Franscisco, CA, USA
06 August 2009 - 07 August 2009

Welcome to the 2nd Molecular Diagnostics World Congress, this year's event will take place at the South San Francisco Conference Center.
  
Validation of Protein Biomarkers in Tissue Arrays

William Gallagher, Associate Professor of Cancer Biology, University College Dublin, speaking at Cancer Proteomics 2007
Immune Response and Biomarker Profiling Using Human Protein Microarrays

Michael Smith, Scientist, Invitrogen, speaking at Cancer Proteomics 2007
Low Input Array Comparative Genomic Hybridization

Steven Roman, Senior Scientist, Invitrogen Corporation, speaking at Advances in Microarray Technology 2007

Multiplexed Diagnostics 2009 Market Report
Published March 2009

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.

Multiplexed Diagnostics 2008 Market Report
Published May 2008

Multiplexed diagnostics are the wild west of medicine. Technology is established, regulation is limited and the number of new biomarkers exploding. First-movers are grabbing biomarker territories, combining independent measurements for efficiency and mining molecules for multivariate panels. All the while demand is high for improving diagnoses and predicting responses to treatment. The challenges, however, are uncertain reimbursement, unclear business models and ever-intensifying competition. On